Potential Neurovascular Stent Claims Following Recent FDA Safety Alert
Parker Waichman LLP is investigating potential personal injury and defective medical device claims related to adverse events associated with the use of Neurovascular Stents for Stent-Assisted Coiling (SAC) for the treatment of unruptured brain aneurysms. The Food and Drug Administration (FDA) has received adverse event reports … [Read more...]
Is the FDA Removing Bad Food from Shelves Quickly Enough?
The United States Food and Drug Administration has the power to order companies to remove potentially dangerous food items from retailer shelves. However, according to a recent report from The New York Times, the FDA may be dragging its feet a bit—leaving consumers at risk for dangerous food-borne illnesses. Federal investigators … [Read more...]
FDA Likely To Clear Cloned Animals
Does The Cloned Animals Is Safe. After over six years of debating whether consuming meat and milk from cloned animals is safe, the Food and Drug Administration (FDA) is expected to announce that they are. Clones are genetically identical copies whose gene sequencing is not modified. While many consumer groups oppose it, the FDA … [Read more...]
FDA Medication Labeling Changes
FDA Mandate Medication Labeling Changes. Numerous drugs have been approved for use, but that does not necessarily mean that the medical community is aware of all medication side effects. In fact, changes are frequently made to a drug's warning label to reflect the most recent knowledge. For instance, the U.S. Food and Drug … [Read more...]
FDA Tried To Thwart Release Of Vioxx Data
Vioxx Data Of Heart Problems. A Food and Drug Administration researcher was pressured by agency officials who wanted to prevent him from publishing a study that linked painkiller Vioxx to a high rate of heart problems, congressional investigators said yesterday. For the past few months, FDA epidemiologist David Graham was … [Read more...]
FDA Updates Plan for Office in China
FDA Updates In China. In March we reported that the US Food and Drug Administration (FDA) received approval from the US State Department to establish eight full-time, permanent positions at US diplomatic posts in the People's Republic of China, pending authorization from the Chinese government. This was one step in the FDA's plans … [Read more...]
FDA Head Asks Congress for More Funding
FDA Head Ask Congress For More Funding. Beleaguered Food and Drug Commissioner (FDA) Dr. Andrew C. von Eschenbach has finally written Congress saying the FDA needs an immediate $275 million to ensure the safety of imported foods, drugs, and medical devices. The May 5 request was sent to Senator Arlen … [Read more...]
